We had the opportunity to talk to the principal investigator of the TITAN trial, Prof. Dr. K. Chi after he presented the final analysis of this study during the virtual ASCO-GU congress.[1]
In this video Prof. Dr. Chi shares his clinical experience with Erleada (apalutamide) and explains the TITAN study design, patient population, key efficacy and safety results.[1]
.jpg?width=1280&height=720&format=webp&quality=50)
.jpg?width=1280&height=720&format=webp&quality=50)
.jpg?width=1280&height=720&format=webp&quality=50)
